Art

J-GLOBAL ID：201602278249336515   Reference number：16A0760563

The efficacy and safety of re-administration of rasburicase for patients with hematological malignancies

悪性血液疾患患者に対するラスブリカーゼの再投与の有効性と安全性

Author (10)： IMAMURA Kyoko (National Hospital Organization Nagoya Medical Center) ,  SUGIYAMA Keiji (National Hospital Organization Nagoya Medical Center) ,  HASEGAWA Yuta (National Hospital Organization Nagoya Medical Center) ,  NAKAMURA Hiroyuki (National Hospital Organization Nagoya Medical Center) ,  SUZUKI Yasuhiro (National Hospital Organization Nagoya Medical Center) ,  TOKUNAGA Takashi (National Hospital Organization Nagoya Medical Center) ,  MIYATA Yasuhiko (National Hospital Organization Nagoya Medical Center) ,  KUNITOMI Akane (National Hospital Organization Nagoya Medical Center) ,  IIDA Hiroatsu (National Hospital Organization Nagoya Medical Center) ,  NAGAI Hirokazu (National Hospital Organization Nagoya Medical Center)
Material： 日本臨床腫瘍学会学術集会(CD-ROM)  (Program and Abstracts. Annual Meeting of Japanese Society of Medical Oncology (CD-ROM))
Volume： 14th  Page： ROMBUNNO.P2-117  Publication year： 2016 
JST Material Number： L7804B  Document type： Proceedings
Article type： 会議録記事  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： B cell lymphoma ,...
Semi thesaurus term： DLBCL ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0760563&from=J-GLOBAL&jstjournalNo=L7804B") }}

JST classification (3)： Drug therapy(=pharmacotherapy)for hematologic diseases in general  (GK05020P) ,  Treatment for immunologic diseases,allergic diseases.  (GD04030Y) ,  Clinical application of enzyme preparations and inhibitor preparations  (GW21020H)

Terms in the title (6)： 悪性血液疾患 ,  患者 ,  ラスブリカーゼ ,  再投与 ,  有効性 ,  安全性